- Home
- CDTX vs GHI Comparison
CDTX vs GHI Comparison
Compare CDTX & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- GHI
- Stock Information
- Founded
- CDTX 2012
- GHI 1998
- Country
- CDTX United States
- GHI United States
- Employees
- CDTX N/A
- GHI N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- GHI Finance: Consumer Services
- Sector
- CDTX Health Care
- GHI Finance
- Exchange
- CDTX Nasdaq
- GHI Nasdaq
- Market Cap
- CDTX 333.3M
- GHI 269.5M
- IPO Year
- CDTX 2015
- GHI N/A
- Fundamental
- Price
- CDTX $21.68
- GHI $12.00
- Analyst Decision
- CDTX Strong Buy
- GHI Strong Buy
- Analyst Count
- CDTX 8
- GHI 4
- Target Price
- CDTX $41.17
- GHI $16.00
- AVG Volume (30 Days)
- CDTX 157.5K
- GHI 35.3K
- Earning Date
- CDTX 05-08-2025
- GHI 05-07-2025
- Dividend Yield
- CDTX N/A
- GHI 12.33%
- EPS Growth
- CDTX N/A
- GHI N/A
- EPS
- CDTX N/A
- GHI 0.45
- Revenue
- CDTX $302,000.00
- GHI $34,065,322.00
- Revenue This Year
- CDTX N/A
- GHI $224.76
- Revenue Next Year
- CDTX N/A
- GHI $5.50
- P/E Ratio
- CDTX N/A
- GHI $26.81
- Revenue Growth
- CDTX N/A
- GHI N/A
- 52 Week Low
- CDTX $10.14
- GHI $10.12
- 52 Week High
- CDTX $28.42
- GHI $15.31
- Technical
- Relative Strength Index (RSI)
- CDTX 47.21
- GHI 57.03
- Support Level
- CDTX $18.91
- GHI $11.26
- Resistance Level
- CDTX $24.91
- GHI $11.93
- Average True Range (ATR)
- CDTX 1.86
- GHI 0.33
- MACD
- CDTX -0.18
- GHI 0.06
- Stochastic Oscillator
- CDTX 33.41
- GHI 100.00
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.